{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T15:13:04Z","timestamp":1776352384844,"version":"3.51.2"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31991173"],"award-info":[{"award-number":["31991173"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82202977"],"award-info":[{"award-number":["82202977"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31991170"],"award-info":[{"award-number":["31991170"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004921","name":"Shanghai Jiao Tong University","doi-asserted-by":"publisher","award":["FC1199"],"award-info":[{"award-number":["FC1199"]}],"id":[{"id":"10.13039\/501100004921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2021M702161"],"award-info":[{"award-number":["2021M702161"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["2022-I2M-5-01"],"award-info":[{"award-number":["2022-I2M-5-01"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012152","name":"National Postdoctoral Program for Innovative Talents","doi-asserted-by":"publisher","award":["BX20211187"],"award-info":[{"award-number":["BX20211187"]}],"id":[{"id":"10.13039\/501100012152","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.canlet.2026.218464","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T15:39:35Z","timestamp":1774885175000},"page":"218464","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Targeting tumor-intrinsic CDK1\/Cyclin B1 complex improves responses to immunotherapy in pancreatic cancer"],"prefix":"10.1016","volume":"648","author":[{"given":"Botai","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2476-0357","authenticated-orcid":false,"given":"Bowen","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoshuang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyi","family":"Lou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2026.218464_bib1","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S0140-6736(25)00261-2","article-title":"Pancreatic cancer","volume":"405","author":"Stoop","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2026.218464_bib2","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2217\/imt-2016-0142","article-title":"Immunotherapy for pancreatic cancer: present and future","volume":"9","author":"Aroldi","year":"2017","journal-title":"Immunotherapy"},{"key":"10.1016\/j.canlet.2026.218464_bib3","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ccell.2020.02.008","article-title":"Dendritic cell paucity leads to dysfunctional immune surveillance in pancreatic cancer","volume":"37","author":"Hegde","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218464_bib4","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.immuni.2016.03.012","article-title":"Expansion and activation of CD103+ dendritic cell progenitors at the tumor site enhances tumor responses to therapeutic PD-L1 and BRAF inhibition","volume":"44","author":"Salmon","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2026.218464_bib5","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adp3978","article-title":"Combined Flt3L and CD40 agonism restores dendritic cell\u2013driven T cell immunity in pancreatic cancer","volume":"10","author":"Hogg","year":"2025","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.canlet.2026.218464_bib6","doi-asserted-by":"crossref","DOI":"10.1126\/science.adh4567","article-title":"Type I conventional dendritic cells facilitate immunotherapy in pancreatic cancer","volume":"384","author":"Mahadevan","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.canlet.2026.218464_bib7","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.immuni.2018.03.004","article-title":"Cancer-cell-intrinsic mechanisms shaping the tumor immune landscape","volume":"48","author":"Wellenstein","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2026.218464_bib8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41577-019-0218-4","article-title":"Tumour-intrinsic resistance to immune checkpoint blockade","volume":"20","author":"Kalbasi","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canlet.2026.218464_bib9","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrc.2017.117","article-title":"Impact of oncogenic pathways on evasion of antitumour immune responses","volume":"18","author":"Spranger","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2026.218464_bib10","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature14404","article-title":"Melanoma-intrinsic \u03b2-catenin signalling prevents anti-tumour immunity","volume":"523","author":"Spranger","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218464_bib11","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1158\/2159-8290.CD-19-0074","article-title":"\u03b2-catenin activation promotes immune escape and resistance to anti\u2013PD-1 therapy in hepatocellular carcinoma","volume":"9","author":"de Galarreta","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2026.218464_bib12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41586-023-05940-w","article-title":"PI3K\u03b2 controls immune evasion in PTEN-deficient breast tumours","volume":"617","author":"Bergholz","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218464_bib13","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1158\/2159-8290.CD-15-0283","article-title":"Loss of PTEN promotes resistance to T cell\u2013mediated immunotherapy","volume":"6","author":"Peng","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2026.218464_bib14","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nature23465","article-title":"CDK4\/6 inhibition triggers anti-tumour immunity","volume":"548","author":"Goel","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218464_bib15","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.molmed.2024.04.014","article-title":"CRISPR\/Cas9 screening: unraveling cancer immunotherapy's \u2018Rosetta stone","volume":"30","author":"Chen","year":"2024","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.canlet.2026.218464_bib16","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41577-022-00802-4","article-title":"CRISPR screens for functional interrogation of immunity","volume":"23","author":"Shi","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canlet.2026.218464_bib17","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.trecan.2018.03.002","article-title":"Cancer CRISPR screens in vivo","volume":"4","author":"Chow","year":"2018","journal-title":"Trends Cancer"},{"key":"10.1016\/j.canlet.2026.218464_bib18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature23643","article-title":"CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity","volume":"549","author":"Burr","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218464_bib19","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/j.ccell.2023.08.008","article-title":"CMTM6 shapes antitumor T cell response through modulating protein expression of CD58 and PD-L1","volume":"41","author":"Miao","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218464_bib20","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.ccell.2023.05.014","article-title":"The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunity","volume":"41","author":"Ho","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218464_bib21","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1158\/2159-8290.CD-20-0812","article-title":"Therapeutically increasing mhc-i expression potentiates immune checkpoint blockade","volume":"11","author":"Gu","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2026.218464_bib22","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1126\/science.aao1710","article-title":"A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing","volume":"359","author":"Pan","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.canlet.2026.218464_bib23","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41586-020-2746-2","article-title":"Functional genomic landscape of cancer-intrinsic evasion of killing by T cells","volume":"586","author":"Lawson","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218464_bib24","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.cmet.2023.07.001","article-title":"Tumor aerobic glycolysis confers immune evasion through modulating sensitivity to T cell-mediated bystander killing via TNF-\u03b1","volume":"35","author":"Wu","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.canlet.2026.218464_bib25","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1158\/2159-8290.CD-19-0780","article-title":"In vivo epigenetic crispr screen identifies asf1a as an immunotherapeutic target in kras-mutant lung adenocarcinoma","volume":"10","author":"Li","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2026.218464_bib26","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/s41590-022-01315-x","article-title":"In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer","volume":"23","author":"Dubrot","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.canlet.2026.218464_bib27","doi-asserted-by":"crossref","first-page":"5357","DOI":"10.1016\/j.cell.2021.09.006","article-title":"In vivo CRISPR screens identify the E3 ligase Cop1 as a modulator of macrophage infiltration and cancer immunotherapy target","volume":"184","author":"Wang","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218464_bib28","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nature23270","article-title":"In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target","volume":"547","author":"Manguso","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218464_bib29","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41586-024-07787-1","article-title":"Glycosphingolipid synthesis mediates immune evasion in KRAS-driven cancer","volume":"633","author":"Soula","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218464_bib30","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/s41586-025-08732-6","article-title":"VDAC2 loss elicits tumour destruction and inflammation for cancer therapy","volume":"640","author":"Yuan","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218464_bib31","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: a major update to the DrugBank database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2026.218464_bib32","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nm.4306","article-title":"The drug repurposing hub : a next-generation drug library and information resource","volume":"23","author":"States","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2026.218464_bib33","article-title":"Module 9: cell cycle and proliferation, cell signal","volume":"6","author":"Berridge","year":"2014","journal-title":"Biol"},{"key":"10.1016\/j.canlet.2026.218464_bib34","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41577-019-0210-z","article-title":"Dendritic cells in cancer immunology and immunotherapy","volume":"20","author":"Wculek","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canlet.2026.218464_bib35","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.it.2016.09.006","article-title":"Dendritic cells and cancer immunity","volume":"37","author":"Gardner","year":"2016","journal-title":"Trends Immunol."},{"key":"10.1016\/j.canlet.2026.218464_bib36","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nri.2017.142","article-title":"NF-B, inflammation, immunity and cancer: coming of age","volume":"18","author":"Taniguchi","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canlet.2026.218464_bib37","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a001651","article-title":"The nuclear factor NF-kappaB pathway in inflammation","volume":"1","author":"Lawrence","year":"2009","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.canlet.2026.218464_bib38","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41568-022-00456-3","article-title":"Targeting CDK4 and CDK6 in cancer","volume":"22","author":"Goel","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2026.218464_bib39","first-page":"1","article-title":"Cyclin D activates the Rb tumor suppressor by mono-phosphorylation","volume":"2014","author":"Narasimha","year":"2014","journal-title":"eLife"},{"key":"10.1016\/j.canlet.2026.218464_bib40","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.molcel.2018.10.034","article-title":"Phosphorylated RB promotes cancer immunity by inhibiting NF-\u03baB activation and PD-L1 expression","volume":"73","author":"Jin","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.canlet.2026.218464_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-36892-4","article-title":"CDK4\/6 inhibition triggers ICAM1-driven immune response and sensitizes LKB1 mutant lung cancer to immunotherapy","volume":"14","author":"Bai","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218464_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-34024-y","article-title":"Retinoblastoma protein as an intrinsic BRD4 inhibitor modulates small molecule BET inhibitor sensitivity in cancer","volume":"13","author":"Ding","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218464_bib43","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2217\/imt-2016-0141","article-title":"Recent progress in GM-CSF-based cancer immunotherapy","volume":"9","author":"Yan","year":"2017","journal-title":"Immunotherapy"},{"key":"10.1016\/j.canlet.2026.218464_bib44","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/sj.cr.7310017","article-title":"Granulocyte-macrophage colony-stimulating factor (GM-CSF) and T-cell responses: what we do and don't know","volume":"16","author":"Shi","year":"2006","journal-title":"Cell Res."},{"key":"10.1016\/j.canlet.2026.218464_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2022.901277","article-title":"GM-CSF: a double-edged sword in cancer immunotherapy","volume":"13","author":"Kumar","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2026.218464_bib46","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.ccell.2020.08.004","article-title":"Challenges and opportunities for pancreatic cancer immunotherapy","volume":"38","author":"Bear","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218464_bib47","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.trecan.2018.04.001","article-title":"Immunotherapy and prevention of pancreatic cancer","volume":"4","author":"Morrison","year":"2018","journal-title":"Trends Cancer"},{"key":"10.1016\/j.canlet.2026.218464_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.102016","article-title":"Immunotherapy for pancreatic cancer: a 2020 update","volume":"86","author":"Schizas","year":"2020","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.canlet.2026.218464_bib49","first-page":"527","article-title":"The tumour microenvironment in pancreatic cancer \u2014 clinical challenges and opportunities, nat. Rev. Clin","volume":"17","author":"Ho","year":"2020","journal-title":"Oncol"},{"key":"10.1016\/j.canlet.2026.218464_bib50","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature25015","article-title":"Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance","volume":"553","author":"Zhang","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218464_bib51","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/j.cell.2022.03.033","article-title":"Quiescent cancer cells resist T cell attack by forming an immunosuppressive niche","volume":"185","author":"Baldominos","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218464_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109271","article-title":"Metabolic modulation by CDK4\/6 inhibitor promotes chemokine-mediated recruitment of T cells into mammary tumors","volume":"35","author":"Uzhachenko","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2026.218464_bib53","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1038\/s41556-024-01509-5","article-title":"Astrocyte-induced Cdk5 expedites breast cancer brain metastasis by suppressing MHC-I expression to evade immune recognition","volume":"26","author":"Yuzhalin","year":"2024","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.canlet.2026.218464_bib54","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ccell.2019.11.003","article-title":"CDK7 inhibition potentiates genome instability triggering anti-tumor immunity in small cell lung cancer","volume":"37","author":"Zhang","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218464_bib55","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-021-00658-5","article-title":"Inflammation and tumor progression: signaling pathways and targeted intervention","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218464_bib56","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41423-021-00756-y","article-title":"Regulation of antitumor immunity by inflammation-induced epigenetic alterations","volume":"19","author":"Karin","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.canlet.2026.218464_bib57","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1084\/jem.20181739","article-title":"Modulating inflammation for cancer therapy","volume":"216","author":"Ritter","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2026.218464_bib58","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218464_bib59","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ni.2035","article-title":"T cell exhaustion","volume":"12","author":"Wherry","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.canlet.2026.218464_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2022.1040163","article-title":"Chronic inflammation, cancer development and immunotherapy","volume":"13","author":"Wen","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.canlet.2026.218464_bib61","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.immuni.2023.09.005","article-title":"CD8+ T cells in the cancer-immunity cycle","volume":"56","author":"Giles","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2026.218464_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","article-title":"Oncology meets immunology: the cancer-immunity cycle","volume":"39","author":"Chen","year":"2013","journal-title":"Immunity"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526002272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526002272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T14:31:26Z","timestamp":1776349886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526002272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":62,"alternative-id":["S0304383526002272"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218464","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting tumor-intrinsic CDK1\/Cyclin B1 complex improves responses to immunotherapy in pancreatic cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218464","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"218464"}}